4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000063
Chief Executive Officer sold 18,700 shares at $33.54 ($627,198)
- Chief Executive Officer acquired 38,277 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,527 | 117,872 | D | ||
| 2025-06-24 | Sale : show line 2 in the form 10b5-1 | −12,471 | $33.54 | $418,277 | 105,401 | D |
| 2025-06-24 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,750 | 118,151 | D | ||
| 2025-06-24 | Sale : show line 4 in the form 10b5-1 | −6,229 | $33.54 | $208,921 | 111,922 | D |
| Open-market sales · 18,700 sh · avg $33.54 · $627,198 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 5 in the form 10b5-1 Performance share units | −25,527 | 51,056 | D |
| 2025-06-24 | Exercise or conversion : show line 6 in the form 10b5-1 Performance share units | −12,750 | 12,750 | D |
Loading xslF345X05/wk-form4_1750972918.xml…